{"id":"NCT01506882","sponsor":"UCB Japan Co. Ltd.","briefTitle":"An Open Label Study of Levetiracetam Monotherapy in Patients With Newly Diagnosed Focal Epilepsy","officialTitle":"An Open-label, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of Levetiracetam Used as Monotherapy in Newly or Recently Diagnosed Epilepsy Patients Aged Older Than or Equal to 16 Years With Partial Seizures","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-12","primaryCompletion":"2013-10","completion":"2015-04","firstPosted":"2012-01-10","resultsPosted":"2014-10-13","lastUpdate":"2015-12-31"},"enrollment":71,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Epilepsy","Partial Onset Seizures"],"interventions":[{"type":"DRUG","name":"Levetiracetam (LEV)","otherNames":["Keppra","E Keppra"]}],"arms":[{"label":"Levetiracetam 1000 mg/day to 2000 mg/day group","type":"EXPERIMENTAL"},{"label":"Levetiracetam 3000 mg/day group","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the efficacy of Levetiracetam (LEV) used as monotherapy, with efficacy measured as 6-month seizure freedom at the last evaluated dose in the LEV 1000 mg/day to 2000 mg/day group, in newly or recently diagnosed epilepsy subjects.","primaryOutcome":{"measure":"Percentage of Subjects in the Levetiracetam (LEV) 1000 mg/Day to 2000 mg/Day Group Who Are Seizure Free for 26 Consecutive Weeks of Treatment During the Evaluation Period","timeFrame":"From the end of the 1-week Stabilization Period over the 26-weeks Evaluation Period","effectByArm":[{"arm":"Levetiracetam 1000 mg/Day to 2000 mg/Day Group","deltaMin":73.8,"sd":null}],"pValues":[{"comp":"OG000","p":null}]},"eligibility":{"minAge":"16 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":5},"locations":{"siteCount":27,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":["http://www.fda.gov/Safety/MedWatch/SafetyInformation/default.htm"]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":61},"commonTop":["Nasopharyngitis","Somnolence","Malaise","Headache","Diarrhoea"]}}